Pre-CKD- Do we Need Another Hero?

被引:4
作者
Malyszko, Jolanta [1 ]
Banach, Maciej [2 ]
机构
[1] Med Univ, Dept Nephrol & Transplantol, PL-15540 Bialystok, Poland
[2] Med Univ Lodz, Dept Hypertens, Lodz, Poland
关键词
Blood pressure; chronic kidney disease; hypertension; prediabetes; prehypertension; CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; IMPAIRED GLUCOSE-TOLERANCE; GLOMERULAR-FILTRATION-RATE; EXPERT CONSENSUS DOCUMENT; NORMAL SERUM CREATININE; CARDIOVASCULAR-DISEASE; RENAL-FUNCTION; FASTING GLUCOSE; BLOOD-PRESSURE;
D O I
10.2174/15701611113119990123
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Screening is the systematic use of a test for a health problem or risk factor when no recognized signs or symptoms would indicate the presence of that problem or risk factor. Abnormal glucose metabolism can be documented years before the onset of overt diabetes. Nowadays, prediabetes can be subdivided into impaired fasting glucose or impaired glucose tolerance. Substantial number of subjects with either will progress to overt diabetes within years. Prediabetes bears also the increased risk of cardiovascular complications. Prehypertension is much newer term introduced by the seventh report of the Joint National Committee (JNC 7) published in 2003 as systolic blood pressure from 120 to 139 mmHg or diastolic blood pressure from 80 to 89 mmHg in adults (not receiving blood pressure-lowering treatment). Similarly prehypertension also increased the risk of cardiovascular complications and progression to hypertension. Chronic kidney disease is also highly prevalent mainly in the elderly. It is associated with important adverse outcomes such as cardiovascular mortality and morbidity. Factors associated with higher risk of chronic kidney disease include mainly hypertension, diabetes, obesity and older age. Early detection and diagnosis of chronic kidney disease may prevent the full blown disease and its end-stage requiring renal replacement therapy. The review focus on the problem of high risk population for development of diabetes, hypertension and whether time has come to focus also on the conditions predisposing to the development of chronic kidney disease.
引用
收藏
页码:642 / 648
页数:7
相关论文
共 88 条
  • [1] [Anonymous], 1986, Br Med J (Clin Res Ed), V293, P988
  • [2] [Anonymous], USRDS 2012 ANN DAT R
  • [3] [Anonymous], 2010, DIABETES CARE, DOI DOI 10.2337/dc10-s062
  • [4] What should the optimal blood pressure goal be in patients with diabetes mellitus or chronic kidney disease?
    Aronow, Wilbert S.
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2012, 8 (03) : 399 - 402
  • [5] Athyros VG, 2011, ARCH MED SCI, V7, P984, DOI [10.5114/AOMS.2011.26610, 10.5114/aoms.2011.26610]
  • [6] The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study
    Athyros, VG
    Mikhailidis, DP
    Papageorgiou, AA
    Symeonidis, AN
    Pehlivanidis, AN
    Bouloukos, VI
    Elisaf, M
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (07) : 728 - 734
  • [7] Undiagnosed renal impairment in patients with and without diabetes with normal serum creatinine undergoing percutaneous coronary intervention
    Bachorzewska-Gajewska, Hanna
    Malyszko, Jolanta
    Malyszko, Jacek S.
    Musial, Wlodzimierz
    Dobrzycki, Slawomir
    [J]. NEPHROLOGY, 2006, 11 (06) : 549 - 554
  • [8] Estimation of glomerular filtration rate in patients with normal serum creatinine undergoing primary PCI: is it really normal?
    Bachorzewska-Gajewska, Hanna
    Malyszko, Jolanta
    Malyszko, Jacek S.
    Dobrzycki, Slawomir
    Sobkowicz, Bozena
    Musial, Wlodzimierz
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (06) : 1736 - 1738
  • [9] The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
    Baigent, Colin
    Landray, Martin J.
    Reith, Christina
    Emberson, Jonathan
    Wheeler, David C.
    Tomson, Charles
    Wanner, Christoph
    Krane, Vera
    Cass, Alan
    Craig, Jonathan
    Neal, Bruce
    Jiang, Lixin
    Hooi, Lai Seong
    Levin, Adeera
    Agodoa, Lawrence
    Gaziano, Mike
    Kasiske, Bertram
    Walker, Robert
    Massy, Ziad A.
    Feldt-Rasmussen, Bo
    Krairittichai, Udom
    Ophascharoensuk, Vuddidhej
    Fellstrom, Bengt
    Holdaas, Hallvard
    Tesar, Vladimir
    Wiecek, Andrzej
    Grobbee, Diederick
    de Zeeuw, Dick
    Gronhagen-Riska, Carola
    Dasgupta, Tanaji
    Lewis, David
    Herrington, William
    Mafham, Marion
    Majoni, William
    Wallendszus, Karl
    Grimm, Richard
    Pedersen, Terje
    Tobert, Jonathan
    Armitage, Jane
    Baxter, Alex
    Bray, Christopher
    Chen, Yiping
    Chen, Zhengming
    Hill, Michael
    Knott, Carol
    Parish, Sarah
    Simpson, David
    Sleight, Peter
    Young, Alan
    Collins, Rory
    [J]. LANCET, 2011, 377 (9784) : 2181 - 2192
  • [10] Hypertension therapy in the older adults-do we know the answers to all the questions? The status after publication of the ACCF/AHA 2011 expert consensus document on hypertension in the elderly
    Banach, M.
    Aronow, W. S.
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2012, 26 (11) : 641 - 643